Enricture is a rapid, cost effective, and low risk screening platform efficient ligand discovery. By combining Affinity Selection–Mass Spectrometry (ASMS) with proprietary AI/ML-driven hit enrichment, it accelerates your drug discovery journey without compromising quality.

Explore how Enricture can transform your drug discovery:

• The unique benefits of Enricture for ligandability assessment and Hit ID
• A breakdown of the highly efficient 3-stage Enricture workflow
• An overview of ASMS technology and its key advantages
• How Evotec integrates existing bioactivity screening data, on-target ASMS results and structural information using proprietary AI/ML algorithms to advance hit enrichment